Denosumab and medication-related osteonecrosis of the jaw (MRONJ)
What MRONJ risk looks like on denosumab, how it differs from bisphosphonate-related risk, and how dose timing changes dental planning.
Never start, stop, or change a medication based on what you read here. Bring questions to your dentist, physician, pharmacist, or prescribing clinician.
Quick answer
Denosumab (Prolia, Xgeva) carries an MRONJ risk similar to bisphosphonates, but managed differently because the drug effect reverses within months of stopping. The osteoporosis dose (Prolia, 60 mg every 6 months) has lower MRONJ rates than the cancer dose (Xgeva, given more frequently). Invasive dental work is often timed in the months before the next scheduled injection, when bone turnover has partially recovered. The right move is not to avoid dental care; it is to coordinate it.
The mechanism
How denosumab MRONJ differs from bisphosphonate MRONJ
Denosumab is a monoclonal antibody that blocks RANK ligand, the signal that activates the osteoclasts which break down bone. Without that signal, bone breakdown slows dramatically, which is what makes denosumab effective for osteoporosis and bone protection during cancer treatment. The downside is that the same suppression of bone turnover slows healing at sites of surgical trauma to the jaw, raising MRONJ risk.
The big difference from bisphosphonates is the duration of effect. Bisphosphonates bind tightly to bone and continue working for years after stopping. Denosumab effects fade within months of the last injection. This makes timing of invasive dental procedures more flexible: in patients on the osteoporosis dose (Prolia every 6 months), there is a recognizable window of partial recovery in the weeks before the next dose where dental surgery is generally safer.
The cancer dose (Xgeva, typically every 4 weeks for bone metastases or multiple myeloma) is given more frequently and at higher cumulative doses than Prolia. MRONJ rates with Xgeva are substantially higher than with Prolia. Patients on Xgeva need much more careful coordination between their oncology team and their dentist before any invasive dental work.
Practical steps
What to do if you are on denosumab and need dental work
Signs to watch for
When to call your dentist
- An exposed area of bone in the mouth, even if it is not painful.
- A tooth socket that is not healing weeks after an extraction.
- Persistent jaw pain in the area of a recent procedure.
- A non-healing sore on the gums that has been there more than two weeks.
- Numbness or tingling in the jaw, lip, or chin (this can be a sign of bone involvement).
Common questions
What patients ask about Denosumab (Prolia) and jaw bone problems (mronj)
KYT Framework
KYT Framework connection
Four questions that shape how Denosumab (Prolia) and jaw bone problems (mronj) factor into dental planning.
Structure
Does jaw bone problems (mronj) change bone, gum tissue, saliva, enamel, or healing support?
Force
Will chewing, grinding, or bite pressure create added risk for vulnerable teeth or healing tissue?
Timing
Is jaw bone problems (mronj) something to prevent now, monitor, or evaluate soon?
Stability
What plan gives the mouth the best chance to stay stable?
Next steps
What to do about jaw bone problems (mronj)
The medication side is usually not the right thing to change. The dental side is. Here is where to go next.
Condition
Jaw osteonecrosis (MRONJ)
Risk levels by drug class, route, and duration.
Open →Cost
Extractions on bone-modifying meds
Why these cases often need atraumatic technique and pre-treatment coordination.
Open →Next step
Pre-treatment consultation
If you are going to start one of these meds, see a dentist first.
Open →More about Denosumab (Prolia)
Other medications and jaw bone problems (mronj)
Taking Denosumab (Prolia) and noticing jaw bone problems (mronj) changes?
Bring your medication list. KYT can evaluate cavity risk, gum health, and treatment timing in person.
Reviewed by Dr. Isaac Sun, DDS · KYT Dental Services · Fountain Valley, CA · Last reviewed: June 2026
This page is general patient education. It does not replace advice from your prescribing clinician, physician, pharmacist, or dentist. Medication information may change; verify with your clinical team.